The Robert E. Fitzhenry Vector Laboratory has played a pivotal role in the development of immunotherapies in Canada. It was the first academic GMP facility in Canada that has manufactured viral vectors approved for use by Health Canada for human clinical trials in 2009. We are committed to supporting translational medicine by providing virus-vector manufacturing services to researchers who want to move forward to clinical trial testing of their product.
For further information, please contact:
Maria Fe C. Medina
Manager, Robert E.Fitzhenry Vector Laboratory
P: 905-525-9140 ext. 22946
Clinical Lots Manufactured to date: